you ever invested in biotech or tech looking to commercialise IP. They don’t produce revenue so their only means of progression is raising capital. However 43% of every dollar spent likely palace for R&D grant rebate so that stretches the research dollars 43% further than the technical cash position.
Ann: Investor Presentation, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BB1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.12pm 26/07/2024 (20 minute delay) ? |
| BB1 (ASX) Chart |
Day chart unavailable